Evaluation of oral small molecule drugs for the treatment of COVID-19 patients: a systematic review and network meta-analysis
AbstractIntroduction At present, there are some randomized controlled trials (RCTs) of oral small molecule drugs. The purpose of this study was to evaluate the efficacy and safety of oral small molecule drug treatment for COVID-19.Methods RCTs were identified through systematic searches of PubMed, E...
Main Authors: | Zhaoyan Chen, Fangyuan Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2023.2274511 |
Similar Items
-
Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis
by: Zhaoyan Chen, et al.
Published: (2023-09-01) -
Development of Small-Molecule MERS-CoV Inhibitors
by: Ruiying Liang, et al.
Published: (2018-12-01) -
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
by: Rong Xiang, et al.
Published: (2022-04-01) -
Safety of hydroxychloroquine for treatment or prevention of SARS‐CoV‐2 infection: A rapid systematic review and meta‐analysis of randomized clinical trials
by: Alberto Enrico Maraolo, et al.
Published: (2021-03-01) -
Clinical efficacy of N-acetylcysteine for COVID-19: A systematic review and meta-analysis of randomized controlled trials
by: Ting-Hui Liu, et al.
Published: (2024-02-01)